Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1000, Issue , 2015, Pages 14-21

  Cífková, Eva ^a   Holčapek, Michal ^a   Lísa, Miroslav ^a   Vrána, David ^b   Melichar, Bohuslav ^b   Študent, Vladimír ^b  

^a UNIVERSITY OF PARDUBICE   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Glycerophospholipids; HILIC HPLC ESI MS; Kidney cancer; Lipidomics; Multivariate data analysis

Indexed keywords

DATA HANDLING; DISEASES; DRUG PRODUCTS; ELECTRODEPOSITION; ELECTROSPRAY IONIZATION; HISTOLOGY; HYDROPHILICITY; INFORMATION ANALYSIS; IONIZATION OF LIQUIDS; LEAST SQUARES APPROXIMATIONS; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTIVARIANT ANALYSIS; POSITIVE IONS; TISSUE; TUMORS;

GLYCEROPHOSPHOLIPIDS; HILIC-HPLC/ESI-MS; KIDNEY CANCER; LIPIDOMICS; MULTIVARIATE DATA ANALYSIS;

PRINCIPAL COMPONENT ANALYSIS;

CHOLESTEROL; LIPID; MAMMALIAN TARGET OF RAPAMYCIN; VASCULOTROPIN; GLYCEROPHOSPHOLIPID;

ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL HETEROGENEITY; CLINICAL ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; DOWN REGULATION; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROPHILIC INTERACTION CHROMATOGRAPHY; KIDNEY CANCER; LIMIT OF QUANTITATION; LIPID METABOLISM; LIPIDOMICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPECIES DIFFERENCE; TANDEM MASS SPECTROMETRY; BIOLOGY; CHEMICAL PHENOMENA; CHEMISTRY; KIDNEY; KIDNEY TUMOR; METABOLISM; MULTIVARIATE ANALYSIS; PROCEDURES;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMPUTATIONAL BIOLOGY; GLYCEROPHOSPHOLIPIDS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KIDNEY; KIDNEY NEOPLASMS; LIPIDS; MULTIVARIATE ANALYSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84937682948     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.07.011     Document Type: Article

References (29)

1. Barh D., Carpi A., Verma M., Gunduz M. Cancer Biomarkers 2014, CRC Press, Boca Raton, FL, USA.
2. Pelengaris S., Khan M. The Molecular Biology of Cancer. A Bridge from Bench to Bedside 2013, Wiley-Blackwell, Oxford, UK.
3. Al-Zhoughbi W., Huang J.F., Paramasivan G.S., Till H., Pichler M., Guertl-Lackner B., Hoefler G. Tumor macroenvironment and metabolism. Semin. Oncol. 2014, 41:281.
4. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 2008, 9:162.
5. Arana L., Gangoiti P., Ouro A., Trueba M., Gomez-Munoz A. Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis. 2010, 9:15.
6. Mills G.B., Moolenaar W.H. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer 2003, 3:582.
7. Louie S.M., Roberts L.S., Mulvihill M.M., Luo K.X., Nomura D.K. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2013, 1831:1566.
8. McLaren D.G., Miller P.L., Lassman M.E., Castro-Perez J.M., Hubbard B.K., Roddy T.P. An ultraperformance liquid chromatography method for the normal-phase separation of lipids. Anal. Biochem. 2011, 414:266.
9. Holčapek M., Cífková E., Červená B., Lísa M., Vostálová J., Galuszka J. Determination of nonpolar and polar lipid classes in human plasma, erythrocytes and plasma lipoprotein fractions using ultrahigh-performance liquid chromatography-mass spectrometry. J. Chromatogr. A 2015, 1377:85.
10. Lísa M., Cífková E., Holčapek M. Lipidomic profiling of biological tissues using off-line two-dimensional high-performance liquid chromatography mass spectrometry. J. Chromatogr. A 2011, 1218:5146.
11. Sandra K., Pereira A.D., Vanhoenacker G., David F., Sandra P. Comprehensive blood plasma lipidomics by liquid chromatography/quadrupole time-of-flight mass spectrometry. J. Chromatogr. A 2010, 1217:4087.
12. Han X.L., Yang K., Gross R.W. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom. Rev. 2012, 31:134.
13. Schwudke D., Liebisch G., Herzog R., Schmitz G., Shevchenko A. Lipidomics and Bioactive Lipids 2007, 175. Elsevier Academic Press Inc, San Diego, USA.
14. Yang K., Cheng H., Gross R.W., Han X.L. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem. 2009, 81:4356.
15. Scherer M., Leuthauser-Jaschinski K., Ecker J., Schmitz G., Liebisch G. A rapid and quantitative LC-MS/MS method to profile sphingolipids. J. Lipid Res. 2010, 51:2001.
16. Cífková E., Holčapek M., Lísa M. Nontargeted lipidomic characterization of porcine organs using hydrophilic interaction liquid chromatography and off-line two-dimensional liquid chromatography-electrospray ionization mass spectrometry. Lipids 2013, 48:915.
17. Cífková E., Holčapek M., Lísa M., Ovčačíková M., Lyčka A., Lynen F., Sandra P. Nontargeted quantitation of lipid classes using hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry with single internal standard and response factor approach. Anal. Chem. 2012, 84:10064.
18. Sundelin J.P., Stahlman M., Lundqvist A., Levin M., Parini P., Johansson M.E., Boren J. Increased expression of the very low-density lipoprotein receptor mediates lipid accumulation in clear cell renal cell carcinoma. PLoS One 2012, 7:e48694.
19. Dill A.L., Eberlin L.S., Zheng C., Costa A.B., Ifa D.R., Cheng L.A., Masterson T.A., Koch M.O., Vitek O., Cooks R.G. Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry. Anal. Bioanal. Chem. 2010, 398:2969.
20. Jones E.E., Powers T.W., Neely B.A., Cazares L.H., Troyer D.A., Parker A.S., Drake R.R. MALDI imaging mass spectrometry profiling of proteins and lipids in clear cell renal cell carcinoma. Proteomics 2014, 14:924.
21. Pirro V., Eberlin L.S., Oliveri P., Cooks R.G. Interactive hyperspectral approach for exploring and interpreting DESI-MS images of cancerous and normal tissue sections. Analyst 2012, 137:2374.
22. Yoshimura K., Chen L.C., Mandal M.K., Nakazawa T., Yu Z., Uchiyama T., Hori H., Tanabe K., Kubota T., Fujii H., Katoh R., Hiraoka K., Takeda S. Analysis of renal cell carcinoma as a first step for developing mass spectrometry-based diagnostics. J. Am. Soc. Mass Spectrom. 2012, 23:1741.
23. Sullentrop F., Moka D., Neubauer S., Haupt G., Engelmann U., Hahn J., Schicha H. P-31 NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed. 2002, 15:60.
24. Eriksson L., Byrne T., Johansson E., Trygg J., Vikström C. Multi- and Megavariate Data Analysis. Basic Principles and Applications 2013, MKS Umetrics AB, Malmö, Sweden.
25. Kirwan G.M., Johansson E., Kleemann R., Verheij E.R., Wheelock A.M., Goto S., Trygg J., Wheelock C.E. Building Multivariate Systems Biology Models. Anal. Chem. 2012, 84:7064.
26. Trygg J., Wold S. Orthogonal projections to latent structures (O-PLS). J. Chemom. 2002, 16:119.
27. Wold S., Sjostrom M., Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001, 58:109.
28. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226:497.
29. Cífková E., Holčapek M., Lísa M., Vrána D., Gatěk J., Melichar B. Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. Anal. Bioanal. Chem. 2015, 407:991.